Modality Solutions hosted a live webinar entitled, “Cold Chain Validation Best Practices Including CAR T-cell and ADC Immunotherapies” covering a step-by-step cold chain validation guide to meet and exceed increasingly stringent regulatory expectations including immunotherapy and regenerative medicine formulations. Targeting complex cold chain biopharmaceutical industry leaders, the webinar was very well received. Due to the high volume of interest in the topic, Modality Solutions is providing free on-demand replays of the 45-minute presentation. Click here to access the cold chain validation webinar.
“With more than 35 international cold chain regulatory compliance guidance documents, global standards are becoming more comprehensive and increasingly complex,” said Modality Solutions President, Gary Hutchinson. “New therapies, accelerating costs, sustainable technologies, and emerging markets demand validated cold chain networks that consistently produce low-cost and high-quality outcomes for patients–with a minimal variation, delivering value to a company’s supply chain. Our webinar is positioned to help companies build their reputation of reliability with regulators.”
To access the free on-demand replay of “Cold Chain Validation Best Practices Including Immunotherapy,” go to https://modality-solutions.securechkout.com/cold-chain-validation-best-practices-webinar
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
